Johnson & Johnson vaccine trial halted by participant's illness

Johnson & Johnson has paused its COVID-19 vaccine study because one of its participants was taken ill.The 60,000-patient clinical trial met the criteria for a “pausing rule,” reported Stat News, meaning the online system that enrolls patients has been closed and the independent committee that monitors patient safety in the clinical trial will be convened.Johnson & Johnson confirmed that a document obtained by Stat News halting the trial did indicate the study was on hold, saying only that it was due to “an unexplained illness in a study participant,” without providing more detail, the news out…

Read More

HEDGE accordingly